Open registration. Barcelona Satellite, Friday 4th June
Vamos a por la COVID-19
En el IBEC estamos trabajando para descifrar cómo se desarrolla la Covid-19, para poder evitar su avance, encontrar tratamientos más eficaces y mitigar las secuelas de quienes ya la han padecido o la van a padecer.
Nuestro propósito es acelerar esta investigación, por eso esta vez te vamos a pedir algo inusual: "NO TE LAVES LAS MANOS", necesitamos que te impliques.
Researchers from IBEC, in collaboration with an international team, describe the first molecules capable of regulate glycine receptors with light: Glyght and Azo-NZ1. The new molecules are a promising way to study neuronal circuits, to develop drug-based phototherapies non-invasively, and to understand neurological disorders related with the incorrect functioning of glycine receptors, as hyperekplexia, epilepsy and autism.
An international team led by SPECS Lab at the Institute for Bioengineering of Catalonia (IBEC) reveals how the brain improves through self-supervised learning combining an analysis of over three decades of research in neuroscience and artificial intelligence.
IBEC experts participate in the XIV Annual Conference of Biomedical Research Technology Platforms, focusing on research opportunities following the pandemic caused by COVID19. Josep Samitier, Teresa Sanchís and Nuria Montserrat highlight the advances made in nanomedicine and bioengineering for health, and join the voices that recommend increasing resources for the entire sector of basic and clinical research.
Coinciding with International Book Day and Sant Jordi, the Institute for Bioengineering of Catalonia (IBEC) launches the first IBBI comic strip, the first Bioengineering superhero. In this first adventure, IBBI will use its superpowers to generate kidney organoids. This character aims to bring closer bioengineering to the non-scientific public, in an understandable and fun way, one of the disciplines that will mark the medicine of the future.